Table 2.
Groupa | N | n1 | PSR1 (%) | χ2 | P | N | n2 | PSR2 (%) | χ2 | P |
---|---|---|---|---|---|---|---|---|---|---|
Group I | 241 | 77.6 | 23.670 | 0.000 | 104 | 71 | 68.3 | 8.873 | 0.012 | |
Group II | 290 | 86.9c | 45 | 26 | 57.8 | |||||
Group III | 240 | 92.9b | 93 | 44 | 47.3b |
N, Total number; n1, number of positive seroprotection 1 month after vaccination; PSR, positive seroprotection rate; n2, number of positive seroprotection 8 years later.
The chi-square test (after Bonferroni adjustment) was used for multiple comparisonsof the PSR among the three groups.
aParticipants were assigned to one of the three groups depending on the vaccination schedule chosen. Group I: vaccinated at 0–1–3 months; group II: vaccinated at 0–1–6 months; group III: vaccinated at 0–1–12 months.
bP < 0.05, compared with Group I.
cP < 0.05, compared with Group I.